SABBY 13G TZAC 12.18.20

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

December 18, 2020

Accession Number

0001535610-20-000124

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →